Dermatology's shift from topical to systemic
Atopic dermatitis, psoriasis, and alopecia are moving from topical and steroid mainstays to systemic biologic and small-molecule therapy.
Dermatology has been quietly transformed by systemic biologics and small molecules across atopic dermatitis, psoriasis, and alopecia. The story is increasingly access - whose insurance covers what, and where the prior-authorisation hurdles bite.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
- ExplainedWhat is lupus nephritis?
- SnapshotLupus nephritis therapy reference (2026)
- ExplainedWhat is Sjogren disease?
- ExplainedWhat is ANCA-associated vasculitis?
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.